TREND-02 - a Phase II Exploratory De-escalation Trial of Neoadjuvant Sacituzumab Govitecan Plus Tislelizumab (SG/I) in Early Triple-negative Breast Cancer
PHASE2
Refining neoadjuvant chemoimmunotherapy and establishing predictive biomark...
Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer
PHASE3
The primary objective of this study is to compare the progression-free surv...
Status
Active Not Recruiting
Location
Arizona Oncology Associates, PC-Hope,1845 W Orange Grove Rd
Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously Operated on Who Were Not Disease-free.
PHASE3
Open-label, phase III, randomized, stratified (PDL1- vs PDL1+), 3 arms, mul...